ATXN2 (ataxin-2)

Assets acting on this target.

Class
ATXN2-lowering agent (modality not stated in source)
Notes
verified in session 2026-08-25 (owner-delegated review, correction of a wrong draft); source: https://clinicaltrials.gov/study/NCT04494256

Related mechanisms

ATXN2 (ataxin-2) drugs compared

2 drugs, stage by indication
2 drugs acting on ATXN2 (ataxin-2): developer, modality, furthest stage and stage in each indication. Furthest stage first.
DrugDeveloperModalityFurthest stageStage by indication
BIIB105Biogen, Ionis Pharmaceuticalsantisense oligonucleotidePhase 1/2Not recorded
SRP-1004Sarepta TherapeuticsRNAi (siRNA)Phase 1Phase 1 in Spinocerebellar Ataxia Type 2

← all mechanisms